Stay updated on Nivolumab Plus Bevacizumab in GBM Clinical Trial

Sign up to get notified when there's something new on the Nivolumab Plus Bevacizumab in GBM Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nivolumab Plus Bevacizumab in GBM Clinical Trial page

  1. Check
    yesterday
    Change Detected
    Summary
    The ClinicalTrials.gov footer now displays revision v3.8.0 instead of v3.7.2.
    Difference
    0.2%
    Check dated 2026-11-02T00:06:00.000Z thumbnail image
  2. Check
    8 days ago
    Change Detected
    Summary
    A sitewide NIH notice about updates to terminology appears above the study record page, which still displays a 403 error.
    Difference
    1%
    Check dated 2026-10-26T00:00:12.000Z thumbnail image
  3. Check
    14 days ago
    Change Detected
    Summary
    The footer’s site revision label changes from v3.7.1 to v3.7.2 while the page continues to display a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-19T00:37:09.000Z thumbnail image
  4. Check
    22 days ago
    Change Detected
    Summary
    The footer revision label changed from v3.7.0 to v3.7.1, while the study page remains a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-12T00:09:44.000Z thumbnail image
  5. Check
    35 days ago
    Change Detected
    Summary
    The page now shows a 403 Forbidden error, replacing the previously visible study details with an access restriction notice. This appears to be an access issue rather than a substantive update to the page content.
    Difference
    0.5%
    Check dated 2026-09-28T00:26:32.000Z thumbnail image
  6. Check
    43 days ago
    Change Detected
    Summary
    A new Revision: v3.7.0 is added, and several older study documents and contributor references (e.g., Informed Consent Form, Study Protocol, Case Comprehensive Cancer Center, David Peereboom) were removed from the page.
    Difference
    22%
    Check dated 2026-09-20T22:56:38.000Z thumbnail image

Stay in the know with updates to Nivolumab Plus Bevacizumab in GBM Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nivolumab Plus Bevacizumab in GBM Clinical Trial page.